-
Mashup Score: 22First prospective Indian thrombectomy registry shows high revascularisation rates and confirms procedure is cost effective - 2 day(s) ago
Data from a registry claimed to be the first prospective registry on mechanical thrombectomy for stroke in India has revealed a number of key insights on how this treatment is being implemented across the country. High revascularisation rates and good functional outcomes, as well as workflow metrics that are “comparable” with those seen in other […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 26TASTE-2 results suggest ‘significant reduction’ in stroke-related disability with Sanbexin - 11 day(s) ago
Simcere Pharmaceutical Group has announced that a new study with major clinical findings regarding Sanbexin—an edaravone-dexborneol concentrated solution for injection—was recently presented at the 16th World Stroke Congress (WSC; 23–26 October, Abu Dhabi, United Arab Emirates). According to the data, the administration of Sanbexin prior to undergoing an endovascular thrombectomy procedure significantly improved neurofunctional recovery and […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet-
TASTE-2 results suggest ‘significant reduction’ in stroke-related disability with Sanbexin https://t.co/qCuriKSvXa
-
-
Mashup Score: 4
Today, on World Stroke Day (29 October), here is a timely reminder that stroke is the second leading cause of death globally. Despite the revolution offered by mechanical thrombectomy that began over a decade ago and the evidence base from multiple trials showing that thrombectomy increases survival and decreases disability, only 5% of the planet’s […]
Source: neuronewsinternational.comCategories: General Medicine News, Future of MedicineTweet-
Today is #WorldStrokeDay. My interview with @NN_publishing on the importance of all physicians to engage with policy-makers to drive change. Including at the recent @UN General Assembly stroke event. https://t.co/kMmbFR4HSj
-
-
Mashup Score: 1World Stroke Day 2024: WSO launches global coalition to drive policy action on stroke care - 15 day(s) ago
Today, on World Stroke Day (29 October), the World Stroke Organization (WSO) has announced the launch of a global coalition aimed at accelerating policy action on stroke—which is currently the second leading cause of death and the third leading cause of disability worldwide. Over the past three decades, the global burden of stroke has doubled, […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet-
World Stroke Day 2024: WSO launches global coalition to drive policy action on stroke care https://t.co/IsGOQ1f5eF @WorldStrokeOrg
-
-
Mashup Score: 6
This year, 25 October marks a full decade since the initial presentation of results from the MR CLEAN randomised controlled trial (RCT), which—along with multiple other RCTs—instigated the rapid expansion of mechanical thrombectomy in the treatment of acute ischaemic stroke. Here, two of MR CLEAN’s leading clinical investigators, Charles Majoie (Amsterdam, The Netherlands) and Diederik […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet-
Ten years of MR CLEAN: stroke thrombectomy’s evolution and ongoing challenges https://t.co/AZ0xDp0MXC
-
-
Mashup Score: 3Remedy announces US FDA orphan drug designation to treat large-territory acute ischaemic stroke with Cirara - 20 day(s) ago
Remedy Pharmaceuticals has announced that the US Food and Drug Administration (FDA) Office of Orphan Products Division (OOPD) has granted orphan drug designation to its stroke drug Cirara for the treatment of large-territory acute ischaemic stroke—which includes large hemispheric infarctions (LHI). As detailed by a Remedy press release, LHI is a particularly severe form of […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet-
Remedy announces US FDA orphan drug designation to treat large-territory acute ischaemic stroke with Cirara https://t.co/gsLh2nsg26 https://t.co/1wTovz4VAa
-
-
Mashup Score: 2Neurointerventionists ‘can rarely recover payment’ for out-of-network thrombectomy under US No Surprises Act - 1 month(s) ago
A new study has found that neurointerventionists have “essentially no financially viable access to payment recovery” through the US No Surprises Act (NSA) for professional mechanical thrombectomy out-of-network (OON) claims. The study—led by the Harvey L Neiman Health Policy Institute (HPI; Reston, USA) and recently published in the Journal of NeuroInterventional Surgery (JNIS)—generated its findings […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet-
Neurointerventionists ‘can rarely recover payment’ for out-of-network thrombectomy under US No Surprises Act https://t.co/VXvRURTj9Y https://t.co/TbM4I9HNXg
-
-
Mashup Score: 0Siemens Healthineers to co-lead EU UMBRELLA project aimed at improving stroke management - 1 month(s) ago
Siemens Healthineers has announced today that it will be joining forces with more than 20 industry and public partners—including seven leading stroke hospitals—to improve stroke management for patients across Europe. With a total volume of €26.9 million, the five-year ‘UMBRELLA’ project is being funded partly by the Innovative Health Initiative (IHI), a public-private partnership for health […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet-
Siemens Healthineers to co-lead EU UMBRELLA project aimed at improving stroke management https://t.co/EeS6y97oFh
-
-
Mashup Score: 7Roughly half of all healthy life lost to stroke is caused by haemorrhagic subtype, new study suggests - 2 month(s) ago
The latest analysis of the Global Burden of Disease, Injuries and Risk Factors study (GBD), assessing data ranging from 1990–2021, has indicated that roughly half of all healthy years of life lost due to stroke worldwide are caused by haemorrhagic stroke—despite it being almost half as common as ischaemic stroke. The analysis revealed that, with […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet-
Roughly half of all healthy life lost to stroke is caused by haemorrhagic subtype, new study suggests https://t.co/3mdtwt4Qlr https://t.co/80k8i776ZR
-
-
Mashup Score: 2Toro Neurovascular announces first patient treatment in clinical trial of SuperBore aspiration catheter - 2 month(s) ago
Toro Neurovascular has announced the successful treatment of the first patient using its Toro 88 SuperBore aspiration catheter as part of a first-in-man clinical study. The procedure—performed by Nobuyuki Sakai and his staff at Seijinkai Shimizu Hospital in Kyoto, Japan—marks “a key milestone in Toro’s mission to transform stroke treatment through cutting-edge technology”, as stated […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet-
Toro Neurovascular announces first patient treatment in clinical trial of SuperBore aspiration catheter https://t.co/eZkWbudaVI
-
First prospective Indian thrombectomy registry shows high revascularisation rates and confirms procedure is cost effective https://t.co/WYiSBi2kPw https://t.co/8cisKjhObn